The week that was

Not like we need more reasons to call this the wacky world of diabetes but take a look at these items;

1. As trading begins today Dexcom, Insulet and Tandem – the Three Amigos of diabetes tech – are all well off their lows. Dexcom and Insulet have recovered so well both are within spitting distance of their 52 week HIGH. Tandem still has a ways to go to reach that level but the trend is upward.

2. Livongo is not just well off their lows but is having one hell of a week approaching levels not seen since their IPO.

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2020 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.